Heart failure

@article{McMurray2005HeartF,
  title={Heart failure},
  author={J. McMurray and M. Pfeffer},
  journal={The Lancet},
  year={2005},
  volume={365},
  pages={1877-1889}
}
  • J. McMurray, M. Pfeffer
  • Published 2005
  • Medicine
  • The Lancet
  • Although heart failure is common, disabling, and deadly, there are now many effective treatments, at least for patients with low left-ventricular ejection fraction. For all, angiotensin-converting-enzyme inhibitors and beta blockers are the essential disease-modifying treatments, improving symptoms, reducing hospital admissions, and increasing survival. Implantable cardioverter defibrillators also improve survival. For patients with persistent symptoms, angiotensin-receptor blockers and… CONTINUE READING
    75 Citations

    Paper Mentions

    Interventional Clinical Trial
    To assess the effect of ARNI on myocardial deoxygenation at stress and myocardial fibrosis, and correlate this to changes in myocardial systolic and diastolic function in HFpEF… Expand
    ConditionsHeart Failure With Preserved Ejection Fraction
    InterventionDrug
    Systolic and diastolic heart failure: differences and similarities.
    • 152
    • PDF
    Management of atrial fibrillation in patients with heart failure.
    • 34
    • PDF
    Use of different types of angiotensin converting enzyme inhibitors and mortality in systolic heart failure.
    • 11
    Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure. - A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)-.
    • 36
    A 108-Year-Old Centenarian Survivor of Acute Decompensated Heart Failure and Acute Kidney Injury.
    • 1
    Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?
    • 20
    Recent Developments in Imaging of Myocardial Angiotensin Receptors
    • 1